house · trading 2015-09-22 → 2015-09-22
*Notional-weighted price return on disclosed buys from the last ~3 years, marked to the latest close — open positions, per-share (share counts aren't disclosed, so this is price performance, not realized $ P&L).
| Date | Ticker | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2015-09-22 | GSK | SELL | $1K–$15K | $38.69 | $52.29 2026-07-13 | 0.0% rt |
| 2015-09-22 | GSK | BUY | $1K–$15K | $38.69 | $52.29 2026-07-13 | +35.1% |
| 2015-09-22 | CSCO | SELL | $1K–$15K | $25.14 | $119.25 2026-07-13 | 0.0% rt |
| 2015-09-22 | CSCO | BUY | $1K–$15K | $25.14 | $119.25 2026-07-13 | +374.3% |
| 2015-09-22 | KO | SELL | $1K–$15K | $38.79 | $84.25 2026-07-13 | -117.2% exit |
| 2015-09-22 | KO | BUY | $1K–$15K | $38.79 | $84.25 2026-07-13 | +117.2% |
Return: buys are marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (how the stock moved after the sale, seller's perspective).
| Member | Shared tickers |
|---|---|
| James B. Renacci | 3 · KO, CSCO, GSK |
| Thomas H Tuberville | 3 · KO, CSCO, GSK |
| K. Michael Conaway | 3 · KO, CSCO, GSK |
| David P. Roe | 3 · KO, CSCO, GSK |
| Rohit Khanna | 3 · KO, CSCO, GSK |
| Katherine M. Clark | 3 · KO, CSCO, GSK |
| Patty Murray | 3 · KO, CSCO, GSK |
| John Rutherford | 3 · KO, CSCO, GSK |
| Fred Upton | 3 · KO, CSCO, GSK |
| David A Perdue , Jr | 2 · KO, CSCO |
| Thomas R Carper | 2 · CSCO, GSK |
| Sheldon Whitehouse | 2 · KO, CSCO |